David O. Watson insider trades
Open-market stock purchases and sales by David O. Watson, General Counsel at Apellis Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 16, 2018.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Bought (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Bought (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Bought (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Bought (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $1.6M |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $209K |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $1.8M |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $1.7M |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $2M |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $2M |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $2.3M |
| Jan 28, 2026 | APLS Apellis Pharmaceuticals, Inc | Bought (not open market) | — |
| Jan 22, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold | $170K |
| Jan 20, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold | $49K |
Companies traded
- APLS Apellis Pharmaceuticals, Inc: 39 sales, last May 14, 2026